Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Non Operating Income: 2020-2025

Historic Non Operating Income for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $10.8 million.

  • IDEAYA Biosciences' Non Operating Income fell 28.40% to $10.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.8 million, marking a year-over-year increase of 11.17%. This contributed to the annual value of $52.5 million for FY2024, which is 144.54% up from last year.
  • IDEAYA Biosciences' Non Operating Income amounted to $10.8 million in Q3 2025, which was down 21.94% from $13.8 million recorded in Q4 2024.
  • IDEAYA Biosciences' 5-year Non Operating Income high stood at $15.1 million for Q3 2024, and its period low was $104,000 during Q2 2021.
  • For the 3-year period, IDEAYA Biosciences' Non Operating Income averaged around $9.4 million, with its median value being $10.8 million (2025).
  • Its Non Operating Income has fluctuated over the past 5 years, first soared by 1,328.03% in 2022, then dropped by 28.40% in 2025.
  • Quarterly analysis of 5 years shows IDEAYA Biosciences' Non Operating Income stood at $157,000 in 2021, then skyrocketed by 1,328.03% to $2.2 million in 2022, then surged by 255.13% to $8.0 million in 2023, then soared by 73.65% to $13.8 million in 2024, then fell by 28.40% to $10.8 million in 2025.
  • Its last three reported values are $10.8 million in Q3 2025, $13.8 million for Q4 2024, and $15.1 million during Q3 2024.